La catena delle opzioni mostra i dati chiave delle opzioni azionarie di OFS Capital a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per OFS Capital..

OFS Capital (NASDAQ:OFS) Azioni, Catena delle Opzioni

OFS Capital

OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.

OFS Capital Corporation - Closed End Fund

OFS Capital Corp

OMNI FINCL SERVICES INC by Omni Financial Services, Inc.

Omni Financial Services Inc

OFS Capital Corporation - 4.95% Notes due 2028

CARBON STREAMING CORP by Carbon Streaming Corporation

Carbon Streaming Corp

Carbon Streaming Corp Warrants (02/03/2026)

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.33 by 21.21 percent. This is a 38.1 percent decrease over earnings of $0.42 per share from the same period last year. The company reported quarterly sales of $10.29 million which missed the analyst consensus estimate of $11.90 million by 13.49 percent. This is a 27.67 percent decrease over sales of $14.23 million the same period last year.

Earnings

Earnings Misses

News

OFS Capital Q1 Adj. EPS $0.26 Misses $0.33 Estimate, Sales $10.29M Miss $11.90M Estimate

AAMI

AAPL

ABNB

ACCO

ADPT

AGCO

AGIO

ALHC

ALKS

ALNY

ALSN

AMGN

AMWL

AMZN

APLE

APTV

ARDX

ARVN

ASND

ASPS

ASUR

ATEC

ATEN

AXTI

BBAI

BIIB

BJRI

BLDR

BMRN

BOOM

BPMC

BRFH

CABO

CARR

CART

CERS

CMLS

COHN

COHU

COLM

COMM

COOK

CRAI

CTRE

CUBE

CWST

DBRG

DINO

DSGR

DUOL

DXCM

ECVT

ELME

Earnings Scheduled For May 1, 2025

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.23 by 30.43 percent. This is a 14.29 percent decrease over earnings of $0.35 per share from the same period last year. The company reported quarterly sales of $11.65 million which beat the analyst consensus estimate of $10.30 million by 13.09 percent. This is a 13.61 percent decrease over sales of $13.48 million the same period last year.

Earnings Beats

OFS Capital Q4 Adj EPS $0.30 Beats $0.23 Estimate, Sales $11.65M Beat $10.30M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Sphere Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPHR#NYSE">SPHR</a>) is expected to report earnings for its second quarter. 
• TG Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGTX#NASDAQ">TGTX</a>) is expected to report quarterly earnings at $0.08 per share on revenue of $99.36 million. 
• Plug Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) is estimated to report quarterly loss at $0.19 per share on revenue of $274.06 million. 
• Burford Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUR#NYSE">BUR</a>) is projected to report quarterly earnings at $0.59 per share on revenue of $216.00 million. 
• Avadel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $52.70 million. 
• Mersana Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRSN#NASDAQ">MRSN</a>) is projected to report quarterly loss at $0.16 per share on revenue of $7.64 million. 
• AG Mortgage IT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MITT#NYSE">MITT</a>) is estimated to report quarterly earnings at $0.20 per share on revenue of $17.01 million. 
• Syndax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDX#NASDAQ">SNDX</a>) is likely to report quarterly loss at $1.07 per share on revenue of $21.98 million. 
• Nomad Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOMD#NYSE">NOMD</a>) is estimated to report quarterly earnings at $0.38 per share on revenue of $796.56 million. 
• Ocular Therapeutix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCUL#NASDAQ">OCUL</a>) is projected to report quarterly loss at $0.22 per share on revenue of $16.89 million. 
• BioLife Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLFS#NASDAQ">BLFS</a>) is expected to report quarterly loss at $0.03 per share on revenue of $22.77 million. 
• Surgery Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRY#NASDAQ">SGRY</a>) is projected to report quarterly earnings at $0.49 per share on revenue of $828.01 million. 
• N-able (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NABL#NYSE">NABL</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $113.77 million. 
• Ready Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RC#NYSE">RC</a>) is estimated to report quarterly earnings at $0.26 per share on revenue of $55.44 million. 
• Hut 8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) is likely to report quarterly loss at $0.35 per share on revenue of $25.62 million. 
• Stereotaxis (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/STXS#AMEX">STXS</a>) is expected to report quarterly loss at $0.06 per share on revenue of $6.42 million. 
• Sunnova Energy Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) is likely to report quarterly loss at $0.67 per share on revenue of $234.99 million. 
• GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) is likely to report earnings for its fourth quarter. 
• Fortrea Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) is likely to report quarterly earnings at $0.37 per share on revenue of $703.90 million. 
• California Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRC#NYSE">CRC</a>) is expected to report quarterly earnings at $1.02 per share on revenue of $904.91 million. 
<h3>Companies Reporting After The Bell</h3>
• NuScale Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) is estimated to report quarterly loss at $0.12 per share on revenue of $1.07 million. 
• B. Riley Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RILY#NASDAQ">RILY</a>) is likely to report earnings for its fourth quarter. 
• ADMA Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NASDAQ">ADMA</a>) is projected to report quarterly earnings at $0.16 per share on revenue of $113.40 million. 
• Ekso Bionics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) is expected to report quarterly loss at $0.08 per share on revenue of $5.30 million. 
• GigaCloud Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCT#NASDAQ">GCT</a>) is projected to report quarterly earnings at $0.88 per share on revenue of $288.33 million. 
• Smart Sand (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SND#NASDAQ">SND</a>) is likely to report quarterly earnings at $0.09 per share on revenue of $65.90 million. 
• OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) is estimated to report quarterly earnings at $0.23 per share on revenue of $10.30 million. 
• Fractyl Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GUTS#NASDAQ">GUTS</a>) is likely to report earnings for its fourth quarter. 
• Crawford &amp; Company Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) is estimated to report quarterly earnings at $0.23 per share on revenue of $334.82 million. 
• MRC Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRC#NYSE">MRC</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $726.90 million. 
• W&amp;T Offshore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTI#NYSE">WTI</a>) is expected to report quarterly loss at $0.25 per share on revenue of $130.04 million. 
• Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) is estimated to report quarterly earnings at $1.08 per share on revenue of $95.23 million. 
• AST SpaceMobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) is expected to report quarterly loss at $0.15 per share on revenue of $1.88 million. 
• Ranger Energy Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNGR#NYSE">RNGR</a>) is projected to report quarterly earnings at $0.18 per share on revenue of $142.60 million. 
• James River Gr Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRVR#NASDAQ">JRVR</a>) is projected to report quarterly loss at $0.46 per share on revenue of $159.91 million. 
• Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) is likely to report quarterly loss at $0.08 per share on revenue of $270.50 million. 
• Repay Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPAY#NASDAQ">RPAY</a>) is expected to report quarterly earnings at $0.25 per share on revenue of $82.56 million. 
• Viant Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSP#NASDAQ">DSP</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $83.91 million. 
• GitLab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) is expected to report quarterly earnings at $0.23 per share on revenue of $206.48 million. 
• Crawford &amp; Company Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) is projected to report quarterly earnings at $0.24 per share on revenue of $334.82 million. 
• Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) is expected to report quarterly loss at $0.06 per share on revenue of $19.83 million. 
• Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) is likely to report quarterly loss at $0.05 per share on revenue of $53.44 million. 
• Senseonics Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SENS#AMEX">SENS</a>) is projected to report quarterly loss at $0.03 per share on revenue of $7.79 million. 
• Quantum-Si (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) is estimated to report quarterly loss at $0.19 per share on revenue of $1.29 million. 
• NCR Atleos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NATL#NYSE">NATL</a>) is estimated to report quarterly earnings at $1.02 per share on revenue of $1.10 billion. 
• Heidrick &amp; Struggles Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSII#NASDAQ">HSII</a>) is expected to report quarterly earnings at $0.63 per share on revenue of $263.33 million. 
• Concentra Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CON#NYSE">CON</a>) is likely to report quarterly earnings at $0.17 per share on revenue of $463.65 million. 
• ThredUp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDUP#NASDAQ">TDUP</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $70.65 million. 
• Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) is expected to report quarterly earnings at $0.74 per share on revenue of $669.10 million. 
• Kayne Anderson BDC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBDC#NYSE">KBDC</a>) is estimated to report earnings for its fourth quarter. 
• BRC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRCC#NYSE">BRCC</a>) is expected to report quarterly loss at $0.05 per share on revenue of $106.20 million. 
• Whitestone REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSR#NYSE">WSR</a>) is expected to report quarterly earnings at $0.26 per share on revenue of $38.39 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADMA

ASTS

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

BDSX

BLFS

BRCC

DAVE

EKSO

FTRE

GTLB

GUTS

HSII

JRVR

KBDC

MITT

MRSN

NABL

NATL

NOMD

NOVA

OCUL

OKTA

PLUG

RILY

RNGR

RPAY

SENS

SGRY

SNDX

SPHR

STXS

TDUP

TGTX

Earnings Scheduled For March 3, 2025

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.26 by 3.85 percent. This is a 32.5 percent decrease over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $10.918 million which missed the analyst consensus estimate of $11.030 million by 1.02 percent. This is a 25.48 percent decrease over sales of $14.651 million the same period last year.

OFS Capital Q3 2024 Adj. EPS $0.27 Beats $0.26 Estimate, Sales $10.918M Miss $11.030M Estimate

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.29 by 10.34 percent. This is a 31.58 percent decrease over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $11.165 million which missed the analyst consensus estimate of $11.740 million by 4.90 percent. This is a 23.14 percent decrease over sales of $14.526 million the same period last year.

OFS Capital Q2 2024 GAAP EPS $0.26 Misses $0.29 Estimate, Sales $11.165M Miss $11.740M Estimate

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.35 by 20 percent. This is a 13.51 percent increase over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $14.233 million which beat the analyst consensus estimate of $13.248 million by 7.44 percent. This is a 0.35 percent decrease over sales of $14.283 million the same period last year.

OFS Capital Q1 2024 Adj EPS $0.42 Beats $0.35 Estimate, Sales $14.233M Beat $13.248M Estimate

WIIM

OFS Capital shares are trading lower after the company reported worse-than-expected Q4 financial results.

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) reported quarterly earnings of $0.35 per share which missed the analyst consensus estimate of $0.39 by 10.26 percent. This is unchanged from the same period last year. The company reported quarterly sales of $13.48 million which missed the analyst consensus estimate of $14.20 million by 5.05 percent. This is a 3.68 percent decrease over sales of $14.00 million the same period last year.

OFS Capital Q4 EPS $0.35 Misses $0.39 Estimate, Sales $13.48M Miss $14.20M Estimate

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-03-05. Here's what investors need to know before the announcement.
Analysts estimate that OFS Capital will report an earnings per share (EPS) of $0.39. 
OFS Capital bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.02, which was followed by a 0.5% increase in the share price the next day.
Here's a look at OFS Capital's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.38</td>
<td>0.35</td>
<td>0.36</td>
<td>0.35</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.40</td>
<td>0.38</td>
<td>0.37</td>
<td>0.35</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>-0.0%</td>
<td>4.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1709575375_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of OFS Capital were trading at $11.43 as of March 01. Over the last 52-week period, shares are up 13.26%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/OFS/earnings">To track all earnings releases for OFS Capital visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

OFS Capital Earnings Preview

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.38 by 5.26 percent. This is a 21.21 percent increase over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $14.65 million which missed the analyst consensus estimate of $14.68 million by 0.20 percent. This is a 9.60 percent increase over sales of $13.37 million the same period last year.

OFS Capital Q3 Adj EPS $0.40 Beats $0.38 Estimate, Sales $14.65M Miss $14.68M Estimate

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.35 by 8.57 percent. This is a 58.33 percent increase over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $14.53 million which beat the analyst consensus estimate of $14.20 million by 2.30 percent. This is a 39.24 percent increase over sales of $10.43 million the same period last year.

OFS Capital Q2 Adj EPS $0.38 Beats $0.35 Estimate, Sales $14.53M Beat $14.20M Estimate

Wednesday marks the last chance for investors to receive the next dividend payout from OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>). 
<h3>What's Happening</h3>
The company announced on Thursday that it would pay shareholders a quarterly dividend of 33 cents per share. On Thursday, OFS Capital will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 33 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Thursday. Shareholders who own OFS as of the end of Wednesday's session are eligible to receive the 33 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on June 30, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/stock//dividends">Click here</a> to find details on OFS Capital's previous dividends.
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Dividends

Wednesday Is Your Last Chance To Buy OFS Capital Before The Dividend Payout

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) reported its Q1 earnings results on Thursday, May 4, 2023 at 04:30 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
OFS Capital beat estimated earnings by 2.78%, reporting an EPS of $0.37 versus an estimate of $0.36.
Revenue was up $3.34 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.0 which was followed by a 5.06% increase in the share price the next day.
Here's a look at OFS Capital's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2022</th>
<th>Q3 2022</th>
<th>Q2 2022</th>
<th>Q1 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.35</td>
<td>0.22</td>
<td>0.30</td>
<td>0.29</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.35</td>
<td>0.33</td>
<td>0.24</td>
<td>0.30</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>13.79M</td>
<td>12.33M</td>
<td>11.68M</td>
<td>11.96M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>14.00M</td>
<td>13.37M</td>
<td>10.43M</td>
<td>10.95M</td>
</tr>
</tbody>
</table>

To track all earnings releases for OFS Capital <a href="https://www.benzinga.com/quote/OFS/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

OFS Capital: Q1 Earnings Insights

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.36 by 8.33 percent. This is a 10 percent increase over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $14.28 million which beat the analyst consensus estimate of $14.15 million by 0.94 percent. This is a 30.49 percent increase over sales of $10.95 million the same period last year.

OFS Capital Q1 EPS $0.33 Misses $0.36 Estimate, Sales $14.28M Beat $14.15M Estimate

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) is set to give its latest quarterly earnings report on Friday, 2023-05-05. Here's what investors need to know before the announcement.
Analysts estimate that OFS Capital will report an earnings per share (EPS) of $0.36. 
OFS Capital bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company missed EPS by $0.00, which was followed by a 0.0% drop in the share price the next day.
Here's a look at OFS Capital's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2022</th>
<th>Q3 2022</th>
<th>Q2 2022</th>
<th>Q1 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.35</td>
<td>0.22</td>
<td>0.30</td>
<td>0.29</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.35</td>
<td>0.33</td>
<td>0.24</td>
<td>0.30</td>
</tr>
<tr>
<td>Price Change %</td>
<td>5.06%</td>
<td>6.96%</td>
<td>-2.3%</td>
<td>0.17%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2023/1683226867_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of OFS Capital were trading at $9.48 as of May 03. Over the last 52-week period, shares are down 24.46%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/OFS/earnings">To track all earnings releases for OFS Capital visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For OFS Capital

On February 28, 2023, our Board of Directors declared a distribution of&nbsp;$0.33&nbsp;per common share for the&nbsp;first quarter&nbsp;of 2023, a&nbsp;10%&nbsp;increase compared to the prior quarter distribution, payable on March 31, 2023 to stockholders of record as of March 24, 2023.

OFS Capital Board Of Directors Increases Quarterly Distribution By 10% To $0.33 Per Share

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) reported quarterly earnings of $0.35 per share which met the analyst consensus estimate. The company reported quarterly sales of $14.00 million which beat the analyst consensus estimate of $13.79 million by 1.51 percent. This is a 8.31 percent decrease over sales of $15.27 million the same period last year.

OFS Capital Q4 Adj EPS $0.35, Inline, Sales $14.00M Beat $13.79M Estimate

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) is set to give its latest quarterly earnings report on Friday, 2023-03-03. Here's what investors need to know before the announcement.
Analysts estimate that OFS Capital will report an earnings per share (EPS) of $0.35. 
OFS Capital bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.11, which was followed by a 0.0% drop in the share price the next day.
Here's a look at OFS Capital's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2022</th>
<th>Q2 2022</th>
<th>Q1 2022</th>
<th>Q4 2021</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.22</td>
<td>0.30</td>
<td>0.29</td>
<td>0.24</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.33</td>
<td>0.24</td>
<td>0.30</td>
<td>0.47</td>
</tr>
<tr>
<td>Price Change %</td>
<td>6.96%</td>
<td>-2.3%</td>
<td>0.17%</td>
<td>7.92%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2023/1677765681_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of OFS Capital were trading at $9.75 as of February 28. Over the last 52-week period, shares are down 10.55%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/OFS/earnings">To track all earnings releases for OFS Capital visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

OFS Capital's Earnings Outlook

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.22 by 50 percent. This is a 32 percent increase over earnings of $0.25 per share from the same period last year.

OFS Capital Q3 EPS $0.33 Beats $0.22 Estimate

Press Releases

OFS Capital Corporation Announces Date for Its Second Quarter 2024 Earnings Release and Conference Call

OFS Capital Corporation Announces Second Quarter 2024 Financial Results

OFS Capital Corporation Announces Date for Its Third Quarter 2024 Earnings Release and Conference Call

OFS Capital Corporation Announces Third Quarter 2024 Financial Results

OFS Capital Corporation Announces Appointment of Kyle Spina as Chief Financial Officer and Treasurer

OFS Capital Corporation Announces Date for Its Fourth Quarter 2024 Earnings Release and Conference Call

OFS Capital Corporation Announces Fourth Quarter 2024 Financial Results

OFS Capital Corporation Announces Date for Its First Quarter 2025 Earnings Release and Conference Call

Comments

OFS Capital

OFS Capital (OFS) Opzioni

OFS Capital (NASDAQ:OFS) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO